MALNIQUE, Fabricio et al. COMBINATION THERAPY WITH ROSUVASTATIN AND EZETIMIBE (TREZETE) IN VERY HIGH CARDIOVASCULAR RISK DYSLIPIDEMIA: EVIDENCE OF EFFICACY AND CLINICAL IMPACT. Seven Editora, [S. l.], p. 316–330, 2025. Disponível em: https://sevenpubl.com.br/editora/article/view/8436. Acesso em: 22 nov. 2025.